Your browser doesn't support javascript.
loading
VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy.
Shekari, Najibeh; Shanehbandi, Dariush; Kazemi, Tohid; Zarredar, Habib; Baradaran, Behzad; Jalali, Seyed Amir.
Affiliation
  • Shekari N; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shanehbandi D; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Kazemi T; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Zarredar H; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Baradaran B; Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Jalali SA; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. baradaranb@tbzmed.ac.ir.
Cancer Cell Int ; 23(1): 265, 2023 Nov 07.
Article in En | MEDLINE | ID: mdl-37936192
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Cell Int Year: 2023 Type: Article Affiliation country: Iran
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Cell Int Year: 2023 Type: Article Affiliation country: Iran